NCT01467817

Brief Summary

The purpose of this study is to determine how exercise and nutritional guidance and supplementation affects your physical fitness, risk for heart disease, your body's ability to burn fat, and your opinions about your health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

September 26, 2011

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 9, 2011

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

November 30, 2016

Status Verified

February 1, 2016

Enrollment Period

6 years

First QC Date

September 26, 2011

Last Update Submit

November 29, 2016

Conditions

Keywords

body massabdominal fatwhole body lean massinsulin resistancecaloric intakeexpenditureenduranceStrengthTC:HDL ratioLDL:HDL ratioarea under the TG response curvefeeding challengefasting and post-prandial whole body fat oxidationHRQoL

Outcome Measures

Primary Outcomes (1)

  • Body mass

    Study specific aims and their accompanying hypotheses will test effect of intervention on:1)reducing body weight and radiographically-derived body fat, 2)improving fitness as assessed by endurance, strength, and anaerobic power,3) reducing risks of fasting dyslipidemia, post-prandial lipemia, and insulin resistance, and 4) enhancing perceived health-related quality of life. the primary trial goal pays fidelity to the DPP by targeting sustained loss of 7% of body weight, a proven countermeasure for prevention of diabetes.

    12 months

Study Arms (2)

Lifestyle Intervention

EXPERIMENTAL

This arm will test the combination of 6 months of structured lifestyle intervention incorporating education, exercise, diet, and behavioral support.

Behavioral: Lifestyle Intervention

Exercise Control

PLACEBO COMPARATOR

This arm will test the benefits of exercise alone while controlling for investigator contact.

Behavioral: Exercise Control

Interventions

The intervention incorporates 6 months of active structured lifestyle intervention containing participant education, exercise, dietary intervention, and behavioral support

Lifestyle Intervention

The control group intervention will test benefits of exercise alone while controlling for investigator contact.

Exercise Control

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • participants will include 64 men and women aged 18-65 years with SCI (AIS A-C) at the C5-L1 levels for more than 1 year.
  • the International Standards for Neurological Classification of SCI (ASIA/ISCoS) will serve as benchmarks for subject classification. A physician-rater experienced in these procedures will classify subjects upon study entry.

You may not qualify if:

  • Study candidates will be excluded from study because of:
  • structured exercise conditioning for recreation or competition within 6 months of study entry;
  • defined diet involving caloric restriction or nutrient modification;
  • weight loss or gain of 5% within the preceding 6 months;
  • surgery within 6 months;
  • pressure ulcer within 3 months;
  • upper limb pain that limits exercise;
  • recurrent acute infection or illness requiring hospitalization or IV antibiotics;
  • pregnancy;
  • previous MI or cardiac surgery;
  • month history of glucose-lowering and lipid-lowering drug therapy;
  • Type I or II diabetes (by WHO criteria); and
  • daily intake of vitamin supplements exceeding 100% RDA.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Of Miami

Miami, Florida, 33136, United States

Location

Related Links

MeSH Terms

Conditions

OverweightObesitySpinal Cord InjuriesInsulin ResistanceFasting

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsSpinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesFeeding BehaviorBehavior

Study Officials

  • Mark S Nash, PhD

    University of Miami

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 26, 2011

First Posted

November 9, 2011

Study Start

September 1, 2010

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

November 30, 2016

Record last verified: 2016-02

Locations